Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fibrosing lung disease with a poor
prognosis. Between 60% and 70% of IPF patients die of IPF; the remaining causes of death …

李国勤教授擅长中西医结合诊治呼吸系统疑难危重症, 对特发性肺纤维化(IPF)
的治疗有独到见解. 李国勤教授认为该病属于中医学“肺痿” 范畴. 肺脾不足, 宗气亏虚为根本 …

Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple
comorbidities, which may influence survival but go under-recognised in clinical practice. We …

Study Objectives: Obstructive sleep apnea (OSA) in patients with idiopathic pulmonary
fibrosis (IPF) is associated with worse mortality and clinical outcome. We aimed to assess …

Aims The “gut-lung axis” reflects intimate connection and bidirectional effect between gut
and lung, involving numerous lung diseases. Pulmonary fibrosis is a progressive interstitial …

Background Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with chronic,
progressive lung fibrosis with a poor prognosis. Recent studies have reported a high …

Fatigue is one of the most burdensome symptoms in interstitial lung disease (ILD) and can
have a major impact on quality of life, social interactions, and work capacity. The cause of …

Idiopathic pulmonary fibrosis (IPF) is a progressive, relentless, and deadly disease. Little is
known about its pathogenetic mechanisms; therefore, developing efficient pharmacological …

Ascariasis is considered the most neglected tropical disease, and is a major problem for the
public health system. However, idiopathic pulmonary fibrosis (IPF) is a result of chronic …